Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2026-2034

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 10.72% from 2026-2034

Unit

Value (USD Billion)

Segmentation

By Type

• Inactivated
• Live Attenuated

By Valency

• Quadrivalent
• Trivalent

By Age Group

• Pediatric
• Adults

By Distribution Channel

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

By Region

• North America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country)
  • U.S. (By Valency)
  • Canada (By Valency)
• Europe (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
  • U.K. (By Valency)
  • Germany (By Valency)
  • France (By Valency)
  • Italy (By Valency)
  • Spain (By Valency)
  • Scandinavia (By Valency)
  • Rest of Europe (By Valency)
• Asia Pacific (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
  • Japan (By Valency)
  • Korea (By Valency)
  • China (By Valency)
  • India (By Valency)
  • Australia (By Valency)
  • Rest of Asia Pacific (By Valency)
• Latin America (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
  • Brazil (By Valency)
  • Mexico (By Valency)
  • Rest of Latin America (By Valency)
• Middle East & Africa (By Type, By Valency, By Age Group, By Distribution Channel, and By Country/Sub-region)
  • GCC (By Valency)
  • South Africa (By Valency)
  • Rest of Middle East & Africa (By Valency)